Schmitt, Volker H.
Leuschner, Anja
Jünger, Claus
Pinto, Antonio
Hahad, Omar
Schulz, Andreas
Arnold, Natalie
Tröbs, Sven-Oliver
Panova-Noeva, Marina
Keller, Karsten
Zeller, Tanja
Beutel, Manfred
Pfeiffer, Norbert
Strauch, Konstantin
Blankenberg, Stefan
Lackner, Karl J.
Prochaska, Jürgen H.
Wild, Philipp S.
Münzel, Thomas http://orcid.org/0000-0001-5503-4150
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (BMBF 01EO1503, BMBF 161L0217A)
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 12 April 2021
Accepted: 25 May 2021
First Online: 24 June 2021
Disclosures
:
: J.H.P. received funding for lecturing by Bayer AG and Boehringer Ingelheim outside the topic of this work. P.S.W. reports the submitted work grants from Bayer AG, non-financial grants from Philips Medical Systems, grants and consulting fees from Boehringer Ingelheim, grants and consulting fees from Novartis Pharma, grants and consulting fees from Sanofi-Aventis, grants, consulting and lecturing fees from Bayer Health Care, grants from Daiichi Sankyo Europe, consulting fees from Astra Zeneca, consulting fees and non-financial support from Diasorin and non-financial support from I.E.M., outside the submitted work. S.O.T has received lecture fees for Philips AG outside the submitted work. All other authors declare no disclosures that could be perceived as conflict of interest in the context of the present work.
: The Gutenberg Health Study (GHS) has been approved by the local ethics committee (reference no. 837.020.07[5555]) and the data protection officer. The GHS therefore has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments as well as the recommendations for Good Clinical and Epidemiological Practice. All study participants gave their written informed consent prior to their inclusion in the study.